Etoposide in combination with intermediate dose cytosine arabinoside (ID ARA C) given with the intention of further myeloablative therapy for the treatment of refractory or recurrent hematological malignancy.

Autor: Whelan, J. S., Davis, C. L., Rohatiner, A. Z. S., Leahy, M., Maccallum, P. K., Gupta, R. K., Matthews, J., Norton, A. J., Amess, J. A. L., Lister, T. A., Rohatiner, A Z, Amess, J A
Zdroj: Hematological Oncology; Mar1992, Vol. 10 Issue 2, p87-94, 8p
Databáze: Complementary Index
Externí odkaz: